Search research articles
Contact Us
Filters
Showing results (181-190 of 187) with videos related to
Page
of 19
Sort By:
You have reached the last page of results.
This site can display upto 187 results.
Science (New York, N.Y.)
|
November 15, 2024
A sample of the Moon's far side retrieved by Chang'e-6 contains 2.83-billion-year-old basalt
Zexian Cui, Qing Yang, Yan-Qiang Zhang, et al.
Clinical Lung Cancer
|
February 8, 2022
Serum Albumin: Early Prognostic Marker of Benefit for Immune Checkpoint Inhibitor Monotherapy But Not Chemoimmunotherapy
Yizhen Guo, Lai Wei, Sandip H Patel, et al.
Leukemia
|
February 3, 2021
Dual targeting of MTOR as a novel therapeutic approach for high-risk B-cell acute lymphoblastic leukemia
Zheng Ge, Chunhua Song, Yali Ding, et al.
Blood
|
May 13, 2020
IKAROS and CK2 regulate expression of BCL-XL and chemosensitivity in high-risk B-cell acute lymphoblastic leukemia
Chunhua Song, Zheng Ge, Yali Ding, et al.
Blood Advances
|
April 12, 2024
Postinfusion PD-1+ CD8+ CAR T cells identify patients responsive to CD19 CAR T-cell therapy in non-Hodgkin lymphoma
Nathan Denlinger, No-Joon Song, Xiaoli Zhang, et al.
Nature Communications
|
January 7, 2023
Dysregulation of PRMT5 in chronic lymphocytic leukemia promotes progression with high risk of Richter's transformation
Zachary A Hing, Janek S Walker, Ethan C Whipp, et al.
The Journal of Clinical Investigation
|
March 20, 2025
TP53 mutations and TET2 deficiency cooperate to drive leukemogenesis and establish an immunosuppressive environment
Pu Zhang, Ethan C Whipp, Sarah J Skuli, et al.
Page
of 19
Search research articles
Search
Showing results (181-190 of 187) with videos related to
Sort By:
Page
of 19
You have reached the last page of results.
This site can display upto 187 results.
Science (New York, N.Y.)
|
November 15, 2024
A sample of the Moon's far side retrieved by Chang'e-6 contains 2.83-billion-year-old basalt
Zexian Cui, Qing Yang, Yan-Qiang Zhang, et al.
Clinical Lung Cancer
|
February 8, 2022
Serum Albumin: Early Prognostic Marker of Benefit for Immune Checkpoint Inhibitor Monotherapy But Not Chemoimmunotherapy
Yizhen Guo, Lai Wei, Sandip H Patel, et al.
Leukemia
|
February 3, 2021
Dual targeting of MTOR as a novel therapeutic approach for high-risk B-cell acute lymphoblastic leukemia
Zheng Ge, Chunhua Song, Yali Ding, et al.
Blood
|
May 13, 2020
IKAROS and CK2 regulate expression of BCL-XL and chemosensitivity in high-risk B-cell acute lymphoblastic leukemia
Chunhua Song, Zheng Ge, Yali Ding, et al.
Blood Advances
|
April 12, 2024
Postinfusion PD-1+ CD8+ CAR T cells identify patients responsive to CD19 CAR T-cell therapy in non-Hodgkin lymphoma
Nathan Denlinger, No-Joon Song, Xiaoli Zhang, et al.
Nature Communications
|
January 7, 2023
Dysregulation of PRMT5 in chronic lymphocytic leukemia promotes progression with high risk of Richter's transformation
Zachary A Hing, Janek S Walker, Ethan C Whipp, et al.
The Journal of Clinical Investigation
|
March 20, 2025
TP53 mutations and TET2 deficiency cooperate to drive leukemogenesis and establish an immunosuppressive environment
Pu Zhang, Ethan C Whipp, Sarah J Skuli, et al.
Page
of 19